Genital Diseases, Female
Welcome,         Profile    Billing    Logout  
 271 Companies   374 Products   374 Products   160 Mechanisms of Action   34 Trials   5514 News 


«12...4849505152535455565758...110111»
  • ||||||||||  dexamethasone injection / Generic mfg.
    Trial primary completion date:  Use of Dexamethasone in Uterine Artery Embolization (clinicaltrials.gov) -  Apr 14, 2015   
    P=N/A,  N=64, Recruiting, 
    Trial primary completion date: Feb 2015 --> Aug 2015 Trial primary completion date: Dec 2014 --> Apr 2015
  • ||||||||||  Enrollment change, Trial withdrawal:  Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) (clinicaltrials.gov) -  Apr 14, 2015   
    P=N/A,  N=0, Withdrawn, 
    Recruiting --> Terminated; The study was terminated due to company restructuring and changes in drug development priorities. N=200 --> 0 | Active, not recruiting --> Withdrawn
  • ||||||||||  Trial primary completion date:  Perceptions of Cervical Cancer Among Asian Americans (clinicaltrials.gov) -  Apr 14, 2015   
    P=N/A,  N=60, Active, not recruiting, 
    Trial primary completion date: Apr 2014 --> Apr 2015 Trial primary completion date: Dec 2015 --> Dec 2016
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection (clinicaltrials.gov) -  Apr 14, 2015   
    P2,  N=0, Withdrawn, 
    Trial primary completion date: Dec 2015 --> Dec 2016 N=20 --> 0 | Not yet recruiting --> Withdrawn | Trial primary completion date: Aug 2018 --> Mar 2015
  • ||||||||||  TheraCIM (nimotuzumab) / Daiichi Sankyo, Oncoscience, Biocon
    Trial completion, Trial initiation date, Metastases:  A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer (clinicaltrials.gov) -  Apr 14, 2015   
    P1/2,  N=15, Completed, 
    Initiation date: Nov 2014 --> Aug 2015 | Trial primary completion date: Sep 2015 --> Jun 2016 Active, not recruiting --> Completed | Initiation date: Jan 2009 --> Jul 2008
  • ||||||||||  Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
    Trial completion, Enrollment change, Trial primary completion date:  VginsmsBOTOX: Injection of Botox in the Perineal Muscles in Resistant Cases of Vaginal Spasm (clinicaltrials.gov) -  Apr 14, 2015   
    P=N/A,  N=32, Completed, 
    Enrolling by invitation --> Completed Recruiting --> Completed | N=20 --> 32 | Trial primary completion date: Dec 2013 --> Mar 2014
  • ||||||||||  Enrollment open, Trial initiation date, Trial primary completion date:  Clinical Utility of Rapid CT/NG Testing in the ED (clinicaltrials.gov) -  Apr 13, 2015   
    P=N/A,  N=300, Recruiting, 
    Recruiting --> Completed | N=20 --> 32 | Trial primary completion date: Dec 2013 --> Mar 2014 Not yet recruiting --> Recruiting | Initiation date: Dec 2014 --> Apr 2015 | Trial primary completion date: Apr 2015 --> Apr 2016
  • ||||||||||  metformin / Generic mfg.
    Trial completion:  Metformin and Oral Contraceptives in PCOS (clinicaltrials.gov) -  Apr 13, 2015   
    P4,  N=90, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed
  • ||||||||||  nimodipine / Generic mfg.
    Enrollment closed, Trial initiation date, Trial primary completion date:  Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients (clinicaltrials.gov) -  Apr 9, 2015   
    P2,  N=90, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial primary completion date: Nov 2011 --> Dec 2013 Not yet recruiting --> Active, not recruiting | Initiation date: Jul 2012 --> Dec 2012 | Trial primary completion date: Aug 2013 --> Apr 2014
  • ||||||||||  Trial completion:  A Two-Phase Clinical Study of the Minerva AURORA Ablation System (clinicaltrials.gov) -  Apr 9, 2015   
    P=N/A,  N=23, Completed, 
    Not yet recruiting --> Active, not recruiting | Initiation date: Jul 2012 --> Dec 2012 | Trial primary completion date: Aug 2013 --> Apr 2014 Active, not recruiting --> Completed
  • ||||||||||  desogestrel / Generic mfg.
    Trial completion, Trial primary completion date, Surgery:  Postoperative Desogestrel for Endometriosis Related Pain (clinicaltrials.gov) -  Apr 9, 2015   
    P=N/A,  N=40, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Oct 2014
  • ||||||||||  Trial completion, Trial primary completion date, Surgery:  Dilators for Dyspareunia Prevention (clinicaltrials.gov) -  Apr 9, 2015   
    P4,  N=60, Completed, 
    Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Oct 2014 Active, not recruiting --> Completed | Trial primary completion date: Sep 2012 --> Aug 2013
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  Vulvar Contact Dermatitis Resulting From Urine Incontinence (clinicaltrials.gov) -  Apr 8, 2015   
    P=N/A,  N=0, Withdrawn, 
    Active, not recruiting --> Completed | Trial primary completion date: Sep 2012 --> Aug 2013 N=400 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Mar 2013 --> Mar 2012
  • ||||||||||  Neupogen (filgrastim) / Kyowa Kirin, Amgen
    Trial completion, Trial initiation date, Trial primary completion date:  Bone Marrow Stem Cell Treatment for Asherman's Syndrome and Endometrial Atrophy (clinicaltrials.gov) -  Apr 8, 2015   
    P4,  N=16, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed | Initiation date: May 2014 --> Apr 2013 | Trial primary completion date: Jan 2015 --> Sep 2014
  • ||||||||||  Trial completion, Trial primary completion date:  Postpartum Dyspareunia Resulting From Vaginal Atrophy (clinicaltrials.gov) -  Apr 8, 2015   
    P=N/A,  N=117, Completed, 
    Recruiting --> Completed | N=150 --> 195 Recruiting --> Completed | Trial primary completion date: Mar 2013 --> Sep 2013
  • ||||||||||  Trial completion:  A Sustainable Approach to Increasing Cancer Screening (clinicaltrials.gov) -  Apr 8, 2015   
    P=N/A,  N=13675, Completed, 
    Active, not recruiting --> Completed | N=358 --> 190 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Cytology:  IBCCSP: Internet-Based Cervical Cytology Screening Program (clinicaltrials.gov) -  Apr 7, 2015   
    P=N/A,  N=175, Completed, 
    Active, not recruiting --> Completed | N=75 --> 53 Active, not recruiting --> Completed | N=500 --> 175
  • ||||||||||  letrozole / Generic mfg.
    Trial completion, Phase classification, Trial primary completion date, IO biomarker:  Letrozole as a Treatment of Endometrial Cancer (clinicaltrials.gov) -  Apr 6, 2015   
    P=N/A,  N=43, Completed, 
    Active, not recruiting --> Completed | N=500 --> 175 Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial primary completion date: Aug 2012 --> Sep 2013
  • ||||||||||  Arenegyr (NGR-hTNF) / AGC Biologics
    Enrollment closed, Trial primary completion date, Combination therapy:  Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer (clinicaltrials.gov) -  Apr 6, 2015   
    P2,  N=124, Active, not recruiting, 
    Recruiting --> Completed | Phase classification: P3 --> PN/A | Trial primary completion date: Aug 2012 --> Sep 2013 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Jun 2016
  • ||||||||||  fenofibrate / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  Effects of Fenofibrate on Metabolic and Reproductive Parameters in Polycystic Ovary Syndrome (clinicaltrials.gov) -  Apr 3, 2015   
    P=N/A,  N=4, Terminated, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2013 --> Jun 2016 N=12 --> 4 | Recruiting --> Terminated | Trial primary completion date: Oct 2011 --> Feb 2015; Poor recruitment
  • ||||||||||  cabergoline / Generic mfg.
    Enrollment closed, Trial primary completion date:  Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) -  Apr 3, 2015   
    P3,  N=300, Active, not recruiting, 
    N=12 --> 4 | Recruiting --> Terminated | Trial primary completion date: Oct 2011 --> Feb 2015; Poor recruitment Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Jul 2015